The Cure Starts Now has funded $24,388,300 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 156 grants at over 100 hospitals in 29 countries.




Stanford University - $200,000

Amount
$200,000.00
Date
October 2017

Targeting neuronal activity regulated DIPG infiltration

Children's Cancer Institute (AU) - $185,706

Amount
$185,706.00
Date
October 2017

Developing novel combination therapeutic approaches for DIPG targeting Polo-like Kinase 1

Children's National Medical Center - $200,000

Amount
$200,000.00
Date
October 2017

Validation of TAK228 as an effective drug for treating children with DIPG

Ann & Robert H. Lurie Children's Hospital - $100,000

Amount
$100,000.00
Date
October 2017

Determine the efficacy of BMP and MEK inhibitors with RT to treat ACVR1 mutant DIPG

Anschutz Medical Campus - $50,000

Amount
$50,000.00
Date
September 2017

Toward a Multimodality Cure for DIPG: Investigation of Intratumoral Drug Penetration and Craniospinal Irradiation.

Massachusetts General Hospital - $50,000

Amount
$50,000.00
Date
September 2017

Repurposing Mefloquine for Diffuse Intrinsic Pontine Glioma Therapy

CONNECT Consortium - $893,678.37

Amount
$893,678.00
Date
September 2017

CONNECT (COllaborative Network for NEurooncology Clinical Trials) Consortium

University of Massachusetts Medical School - $50,000

Amount
$50,000.00
Date
May 2017

Advanced RNAi therapeutics for DIPG

Lucile Packard Children's Hospital Stanford - $50,000

Amount
$50,000.00
Date
May 2017

Cellular Cybercriminals: DIPG Hacks into the Neural Communication Infrastructure

Hospital for Sick Children - $50,000

Amount
$50,000.00
Date
September 2016

MRI Guided Focused Ultrasound: Targeted Drug Delivery in Diffuse Intrinsic Pontine Glioma

Gustave Roussy Cancer Center - $93,071

Amount
$93,071.00
Date
September 2016

Ultrasound-induced delivery of Panobinostat in preclinical models

The Hospital for Sick Children - $194,260

Amount
$194,260.00
Date
September 2016

Exploring the interactome of H3K27M to find therapeutic targets for DIPG

Cold Spring Harbor Laboratory - $100,000

Amount
$100,000.00
Date
September 2016

Allele-specific antisense therapy for DIPG

Children's Cancer Institute - $143,884

Amount
$143,884.00
Date
September 2016

Radiosensitisation of Diffuse Intrinsic Pontine Gliomas by modulating the glucose metabolism

Dana-Farber Cancer Institute - $100,000

Amount
$100,000.00
Date
December 2015

Characterizing resistance mechanisms to radiation therapy and adjuvant chemotherapy in Diffuse Intrinsic Pontine Glioma